Adjuvant therapy with nivolumab combined with ipilimumab vs nivolumab alone in patients with resected stage IIIB-D/IV melanoma

Assessing comprehensive score for financial toxicity (COST) among radiation oncology patients in India

Autologous tumour infiltrating lymphocytes cell therapy in metastatic non-small cell lung cancer

Highlights from AORTIC Cancer Genomics Conference 2021

The Conquering Cancer Campaign

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy

ecancer special issue on medical education in Africa

Cancer Genomics in Africa today

UICC Breast Cancer Programme: update and opportunities

Challenges and solutions in PD-L1 testing in NSCLC

Managing immune-related adverse events

Managing the treatment of NSCLC patients during the COVID-19 pandemic (FR)